AKT1 and neoplasm: Subsequently, treatment with stERAP-6 every 4 days also significantly suppressed E2-induced expression of TFF1 and CCND1 and phosphorylation levels of Akt and MAPK in tumours, but treatment with unstapled original ERAP did not (Fig. 3c,d).